Collegium Provides Litigation Update

CANTON, Mass., Feb. 02, 2016 -- (Healthcare Sales & Marketing Network) -- Collegium Pharmaceutical, Inc. (COLL) today provided an update regarding its ongoing litigation with Purdue Pharma L.P. (“Purdue”). On February 1, 2016, the U.S. Court of Appeals for... Biopharmaceuticals, LitigationCollegium Pharmaceutical, Purdue Pharma, OxyContin OP, Xtampza
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news